MedPath

Study to check safety of products on human volunteers

Not yet recruiting
Conditions
Having Healthy skin on studied anatomic unit
Registration Number
CTRI/2025/02/081224
Lead Sponsor
Geenia International Pvt Ltd
Brief Summary

Objective: The objective of this study will be to evaluate the irritation potential on healthy human subjects of Skin Care Formulations

Duration of study: 8 days study

 Kinetics: T0 (Evaluation of test sites by Dermatologist, Patch application) ,T1(Patch removal, Evaluation of test sites by Dermatologist ,T2(Evaluation of test sites by Dermatologist and Subject post 24 hrs of patch removal), T8 (Evaluation of test sites by Dermat and Subject post 1 week of patch removal and tracking the positive cases)

 Population: 26 healthy subjects (13 males + 13 females) .

The test area is checked for erythema and oedema caused due to the products and compared with positive control

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
26
Inclusion Criteria
  1. Healthy Human Subjects 2) Skin should be healthy on the studied anatomic unit.
Exclusion Criteria
  • 1)For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
  • 2)Having refused to give his/her assent by not signing the consent form.
  • 3)Taking part in another study liable to interfere with this study.
    1. Being diabetic.
    1. Being asthmatic.
    1. Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
  • 7)Having cutaneous hypersensitivity (except in the case of studies with evaluation of sensitive skin).
    1. Having undergone a surgery requiring a general anesthesia of more than one hour in the past 6 months.
    1. Having changed his/her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Dermatological safety / Irritation potential on skinBaseline,0 hrs,24 hrs and 7 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mascot Spincontrol India Pvt. Ltd.

🇮🇳

Mumbai, MAHARASHTRA, India

Mascot Spincontrol India Pvt. Ltd.
🇮🇳Mumbai, MAHARASHTRA, India
Dr Pooja Yadav
Principal investigator
02243349191
poojayadav@mascotspincontrol.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.